TipRanks
Advertisement
Advertisement

NVCT Stock Latest News

Nuvectis: Buy Rating Reaffirmed as NXP Pipeline Progress and Regulatory Momentum Support Unchanged $39 Price Target
RatingsNuvectis: Buy Rating Reaffirmed as NXP Pipeline Progress and Regulatory Momentum Support Unchanged $39 Price Target
5m ago
NVCT
Nuvectis Pharma announces NXP200 granted BTD in China
PremiumThe Fly
Nuvectis Pharma announces NXP200 granted BTD in China
3h ago
NVCT
Some of the Top Biotech Funds Just Bought Into This Under-the-Radar Biotech (NASDAQ: NVCT)
PremiumTipRanks Newswire
Some of the Top Biotech Funds Just Bought Into This Under-the-Radar Biotech (NASDAQ: NVCT)
21d ago
AZN
NVCT
Nuvectis Pharma initiated with an Overweight at Cantor Fitzgerald
PremiumThe Fly
Nuvectis Pharma initiated with an Overweight at Cantor Fitzgerald
1M ago
NVCT
Nuvectis Pharma initiated with an Overweight at Cantor Fitzgerald
PremiumThe Fly
Nuvectis Pharma initiated with an Overweight at Cantor Fitzgerald
1M ago
NVCT
Nuvectis Pharma Launches New $200 Million ATM Program
PremiumCompany AnnouncementsNuvectis Pharma Launches New $200 Million ATM Program
1M ago
8K
NVCT
Nuvectis Pharma files $200M mixed securities shelf
Premium
The Fly
Nuvectis Pharma files $200M mixed securities shelf
1M ago
NVCT
Nuvectis’ NXP800 Ovarian Cancer Trial Terminated: What Investors Should Watch Next
Premium
Company Announcements
Nuvectis’ NXP800 Ovarian Cancer Trial Terminated: What Investors Should Watch Next
2M ago
NVCT
Nuvectis Pharma price target raised to $34 from $22 at Lucid Capital
PremiumThe Fly
Nuvectis Pharma price target raised to $34 from $22 at Lucid Capital
2M ago
NVCT
Nuvectis Pharma’s Heavy Reliance on Haisco Poses Major Operational and Geopolitical Risks
PremiumCompany Announcements
Nuvectis Pharma’s Heavy Reliance on Haisco Poses Major Operational and Geopolitical Risks
2M ago
NVCT
Nuvectis Pharma: Buy Rating Reiterated as Late-Stage Pipeline Expands and $39 Price Target Remains Unchanged
PremiumRatings
Nuvectis Pharma: Buy Rating Reiterated as Late-Stage Pipeline Expands and $39 Price Target Remains Unchanged
2M ago
NVCT
Nuvectis’ NXP100 Just Achieved the First Marketing Approval Ever for a Once-Daily Oral Factor B Inhibitor
PremiumTipRanks Newswire
Nuvectis’ NXP100 Just Achieved the First Marketing Approval Ever for a Once-Daily Oral Factor B Inhibitor
2M ago
NVS
CRNX
Pantginis Reiterates Buy on Nuvectis, Citing Ciprocopan Approval and Pipeline Diversification; Price Target Maintained at $39
PremiumRatingsPantginis Reiterates Buy on Nuvectis, Citing Ciprocopan Approval and Pipeline Diversification; Price Target Maintained at $39
2M ago
NVCT
Nuvectis Pharma receives marketing approval in China for ciprocopan
Premium
The Fly
Nuvectis Pharma receives marketing approval in China for ciprocopan
2M ago
NVCT
Nuvectis Pharma’s NXP900 Combo Trial Adds Fresh Momentum to NVCT in EGFR Lung Cancer
Premium
Company Announcements
Nuvectis Pharma’s NXP900 Combo Trial Adds Fresh Momentum to NVCT in EGFR Lung Cancer
3M ago
NVCT
The Billion-Dollar Pill: With NXP100, Nuvectis Pharma Just Staked Its Claim in the New Biotech Gold Rush
PremiumTipRanks Newswire
The Billion-Dollar Pill: With NXP100, Nuvectis Pharma Just Staked Its Claim in the New Biotech Gold Rush
3M ago
LLY
ABBV
Nuvectis Pharma price target raised to $33 from $20 at Roth Capital
PremiumThe Fly
Nuvectis Pharma price target raised to $33 from $20 at Roth Capital
3M ago
NVCT
Nuvectis Pharma Announces Major Public Equity Offering
PremiumCompany Announcements
Nuvectis Pharma Announces Major Public Equity Offering
3M ago
8K
NVCT
Midday Fly By: Patrick to combine with LCI, AeroVironment reports Q4 beat
PremiumThe Fly
Midday Fly By: Patrick to combine with LCI, AeroVironment reports Q4 beat
3M ago
BX
GS
Nuvectis Pharma 5M share Spot Secondary priced at $20.00
PremiumThe FlyNuvectis Pharma 5M share Spot Secondary priced at $20.00
3M ago
NVCT
Closing Bell Movers: AeroVironment jumps after quarterly report
Premium
The Fly
Closing Bell Movers: AeroVironment jumps after quarterly report
3M ago
TW
AVAV
Nuvectis Pharma TBA Spot Secondary; price range $20.00-$22.00
Premium
The Fly
Nuvectis Pharma TBA Spot Secondary; price range $20.00-$22.00
3M ago
NVCT

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >